ZHENYU XU sells shares under 10b5-1 plan (SOPH)
Rhea-AI Filing Summary
ZHENYU XU reported 10b5-1 sales of Common Stock under multiple transactions. The filing lists periodic 10b5-1 dispositions on 01/05/2026, 01/06/2026, 01/13/2026, 01/20/2026, 02/13/2026, 02/19/2026, and 03/13/2026, with reported share amounts of 2006, 3000, 4000, 608, 4000, 608, and 4000 respectively and per-trade proceeds shown in the filing.
The filing also lists 608 Restricted Stock Units to be sold by the issuer on 03/18/2026. Transactions were processed through Morgan Stanley Smith Barney LLC.
Positive
- None.
Negative
- None.
Insights
Structured sales under a 10b5-1 plan and an issuer-designated RSU sale are reported.
The filing documents multiple 10b5-1 sales by ZHENYU XU across seven dates in Jan–Mar 2026, listing per-transaction share counts: 2006, 3000, 4000, 608, 4000, 608, 4000. The excerpt shows per-trade cash amounts tied to each sale.
The excerpt also shows an issuer sale of 608 Restricted Stock Units on 03/18/2026 processed via Morgan Stanley Smith Barney LLC. Cash-flow treatment is the proceeds to the seller; further filing details would clarify net proceeds and any tax-withholding.
Forms indicate routine, pre-arranged dispositions rather than event-driven market activity.
The entries are labeled as 10b5-1 Sales, which the excerpt identifies by date and share count; such labeling typically denotes pre-planned trading instructions. The filing names the executing broker and records gross proceeds per trade.
Regulatory implications are routine disclosure; further filings may show aggregate totals or confirm whether these trades exhausted a plan, but timing and plan terms are not provided in the excerpt.